OBJECTIVE: To measure immunization coverage among children aged 12-23 months in Papua New Guinea (PNG) and to assess if and why there are differences between hard-to-reach and more accessible communities. METHODS: WHO cluster sampling methodology was employed to measure immunization coverage in PNG's four regions. Survey data were re-analyzed according to a local assessment of geographical accessibility indicated by census unit type: urban, rural and hard-to-reach. Census units were designated as hard-to-reach if they were five or more km from a health centre. FINDINGS: Nationwide coverage for most antigens falls below the national target of 80% although there are regional differences with Islands performing the best. Late doses are a major concern: just 4% were fully immunized with valid ("on time") doses by 1 year of age. Coverage was lower in both rural and remote communities: at 6 months 48% of children from urban units had received three valid doses of DTP-3 but only 16% in rural areas and 13% in hard-to-reach communities. Reasons for failure to immunize varied: 21% of mothers said their child was not immunized because distance, travel conditions or cost of transportation prevented access to local health centres; 27% cited a lack of knowledge or misconceptions about immunization; while 29% believed it was because of an issue with the health system. CONCLUSIONS: Throughout PNG there is an urgent need to increase immunization coverage and to ensure that children are immunized on time according to the schedule. Both coverage and timeliness of doses are worse for children living in hard-to-reach and rural areas. Achieving national immunization targets requires improvements in health service delivery, including outreach, especially for remote and rural communities, as well as greater community education and social mobilisation in support of immunization services. (c) 2010 Elsevier Ltd. All rights reserved.
OBJECTIVE: To measure immunization coverage among children aged 12-23 months in Papua New Guinea (PNG) and to assess if and why there are differences between hard-to-reach and more accessible communities. METHODS: WHO cluster sampling methodology was employed to measure immunization coverage in PNG's four regions. Survey data were re-analyzed according to a local assessment of geographical accessibility indicated by census unit type: urban, rural and hard-to-reach. Census units were designated as hard-to-reach if they were five or more km from a health centre. FINDINGS: Nationwide coverage for most antigens falls below the national target of 80% although there are regional differences with Islands performing the best. Late doses are a major concern: just 4% were fully immunized with valid ("on time") doses by 1 year of age. Coverage was lower in both rural and remote communities: at 6 months 48% of children from urban units had received three valid doses of DTP-3 but only 16% in rural areas and 13% in hard-to-reach communities. Reasons for failure to immunize varied: 21% of mothers said their child was not immunized because distance, travel conditions or cost of transportation prevented access to local health centres; 27% cited a lack of knowledge or misconceptions about immunization; while 29% believed it was because of an issue with the health system. CONCLUSIONS: Throughout PNG there is an urgent need to increase immunization coverage and to ensure that children are immunized on time according to the schedule. Both coverage and timeliness of doses are worse for children living in hard-to-reach and rural areas. Achieving national immunization targets requires improvements in health service delivery, including outreach, especially for remote and rural communities, as well as greater community education and social mobilisation in support of immunization services. (c) 2010 Elsevier Ltd. All rights reserved.
Authors: Bruce Y Lee; Shawn T Brown; Leila A Haidari; Samantha Clark; Taiwo Abimbola; Sarah E Pallas; Aaron S Wallace; Elizabeth A Mitgang; Jim Leonard; Sarah M Bartsch; Tatenda T Yemeke; Eli Zenkov; Sachiko Ozawa Journal: Vaccine Date: 2019-03-25 Impact factor: 3.641
Authors: Christopher Pell; Lianne Straus; Suparat Phuanukoonnon; Sebeya Lupiwa; Ivo Mueller; Nicolas Senn; Peter Siba; Marjolein Gysels; Robert Pool Journal: Malar J Date: 2010-12-22 Impact factor: 2.979
Authors: Yemisrach B Okwaraji; Kim Mulholland; Joanna R M Armstrong Schellenberg; Gashaw Andarge; Mengesha Admassu; Karen M Edmond Journal: BMC Public Health Date: 2012-06-22 Impact factor: 3.295
Authors: Daniel Sánchez; Samir V Sodha; Hannah J Kurtis; Gladys Ghisays; Kathleen A Wannemuehler; M Carolina Danovaro-Holliday; Alba María Ropero-Álvarez Journal: BMC Public Health Date: 2015-04-17 Impact factor: 3.295
Authors: William S Pomat; Anita H J van den Biggelaar; Suparat Phuanukoonnon; Jacinta Francis; Peter Jacoby; Peter M Siba; Michael P Alpers; John C Reeder; Patrick G Holt; Peter C Richmond; Deborah Lehmann Journal: PLoS One Date: 2013-02-22 Impact factor: 3.240